Association Between Intensity of Low-Density Lipoprotein Cholesterol Reduction With Statin-Based Therapies and Secondary Stroke Prevention: A Meta-analysis of Randomized Clinical Trials

IMPORTANCE: The benefits and risks associated with intensive low-density lipoprotein cholesterol (LDL-C)–lowering statin-based therapies to lessen the risk of recurrent stroke have not been established. OBJECTIVE: To conduct a meta-analysis of randomized clinical trials to evaluate the association o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Meng, Cheng, Chun-Yu, Wu, Yi-Ling, Lee, Jiann-Der, Hsu, Chia-Yu, Ovbiagele, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861901/
https://www.ncbi.nlm.nih.gov/pubmed/35188949
http://dx.doi.org/10.1001/jamaneurol.2021.5578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861901/
https://www.ncbi.nlm.nih.gov/pubmed/35188949
http://dx.doi.org/10.1001/jamaneurol.2021.5578

Ejemplares similares